Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Decheng Capital China Life Sciences USD Fund III, L.P.. Insider active across 4 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 13 disclosures have been recorded. Split: 2 buys · 6 sells. Total volume traded: €24.7m. History available since 17 September 2021. The latest transaction was filed on 7 October 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
1,542,553 shares@ US$9.4050.0% of flowCommon StockSEC:0001626199-21-000118
Ideal exit: 14 Jun 2022 (T+270)
13 of 13 declarations
About Decheng Capital China Life Sciences USD Fund III, L.P.
Decheng Capital China Life Sciences USD Fund III, L.P. is a declarant and a 10% Owner of BeyondSpring Inc. The 13 filings on record run from 2021-09-21 to 2025-10-07, and, across the sampled recent filings held, the indicated cumulative amounts are EUR 24644198 in buys and EUR 37180 in sells.